SCHEMBL5637696

SCHEMBL5637696

CC(C)(C)OC(=O)N1CCc2c(c3c(-c4ccc(C(F)(F)F)cc4Cl)ccc4c3n2CCCS4)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.38
ESR2 Q92731 1/20 0.35
CYBB P04839 1/20 0.35
NOX5 Q96PH1 1/20 0.35
NOX4 Q9NPH5 1/20 0.35
NOX1 Q9Y5S8 1/20 0.35
RORC P51449 3/20 0.35
MAPT P10636 1/20 0.35
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
SCN9A Q15858 2/20 0.33
SCN5A Q14524 1/20 0.33
NR1H2 P55055 1/20 0.33
RAF1 P04049 1/20 0.33
BRAF P15056 1/20 0.33
MKNK1 Q9BUB5 3/20 0.33
JAK2 O60674 1/20 0.32
JAK3 P52333 1/20 0.32
PTK2 Q05397 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5636457 0.85 CYBB (0.38) ESR2CYBBNOX5NOX4NOX1
SCHEMBL5638181 0.85 ESR2 (0.37) ESR2CYBBNOX5NOX4NOX1
SCHEMBL5635040 0.81 ESR2 (0.38) ESR2CYBBNOX5NOX4NOX1
SCHEMBL5636204 0.80 ESR2 (0.38) ESR2CYBBNOX5NOX4NOX1
SCHEMBL5507669 0.70 PTGDR2 (0.39) MAPTMEN1KMT2A
SCHEMBL7669092 0.66 MAPT (0.43) GPR119RORCMAPTMEN1KMT2A
SCHEMBL3922455 0.64 GPR119 (0.69) GPR119MAPTMEN1KMT2A
SCHEMBL31142873 0.64 GPR119 (0.69) GPR119MAPTMEN1KMT2A
SCHEMBL24460539 0.63 RYR2 (0.51) GPR119ESR2MAPT
SCHEMBL4791213 0.63 ESR2 (0.44) ESR2CYBBNOX5NOX4NOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39679-E1 Substituted heterocycle fused gamma-carbolines BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-06-05 US disclosed
US-6713471-B1 SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-03-30 US disclosed